Ledger.Open graph →
SEC Form D · filed February 17, 2022

LexaGene Holdings Inc

Offering
$8.1M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEVERLY, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Joseph M. Caruso · Beverly, MADirectorJohn (Jack) F. Regan · Beverly, MAExec · DirectorJeffrey M. Mitchell · Beverly, MAExecStephen J. Mastrocola · Beverly, MADirectorSteven Armstrong · Beverly, MAExecThomas R. Slezak · Beverly, MADirectorJane R. Sykes · Beverly, MADirectorPatrick Townzen · TAMPA, FLExecRon Lockhart · PAOLI, PAExecMatthew Stern · Los Angeles, CADirectorLee Fixel · New York, NYExec · DirectorGheorghe Rotar · TAMPA, FLDirectorRonald Redell · TAMPA, FLDirectorBenjamin Taft · Los Angeles, CADirectorGary Cohn · Cleveland, OHExec · DirectorMark Froimson · Cleveland, OHExecKevin D. Demeritt · Newport Beach, CADirectorLuke V. Carlson · San Francisco, CADirectorKirk Wycoff · Brentwood, TNExecSarah Biller · Brentwood, TNDirectorJohn Philpott · Brentwood, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗